PH21322A - Anti-imflammatory polymorphic monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound; composition and method of use therefor - Google Patents

Anti-imflammatory polymorphic monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound; composition and method of use therefor

Info

Publication number
PH21322A
PH21322A PH33058A PH33058A PH21322A PH 21322 A PH21322 A PH 21322A PH 33058 A PH33058 A PH 33058A PH 33058 A PH33058 A PH 33058A PH 21322 A PH21322 A PH 21322A
Authority
PH
Philippines
Prior art keywords
benzothiazine
carboxamide
pyridyl
hydroxy
methyl
Prior art date
Application number
PH33058A
Other languages
English (en)
Inventor
Robertson Robert Lee
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH21322A publication Critical patent/PH21322A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/161,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16LPIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L57/00Protection of pipes or objects of similar shape against external or internal damage or wear
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
PH33058A 1984-11-16 1985-11-15 Anti-imflammatory polymorphic monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound; composition and method of use therefor PH21322A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/672,028 US4582831A (en) 1984-11-16 1984-11-16 Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor

Publications (1)

Publication Number Publication Date
PH21322A true PH21322A (en) 1987-09-28

Family

ID=24696846

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33058A PH21322A (en) 1984-11-16 1985-11-15 Anti-imflammatory polymorphic monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound; composition and method of use therefor

Country Status (28)

Country Link
US (1) US4582831A (es)
EP (1) EP0182572B1 (es)
JP (1) JPS61122284A (es)
KR (1) KR870000291B1 (es)
CN (1) CN1004001B (es)
AT (1) ATE50257T1 (es)
AU (1) AU556378B2 (es)
CA (1) CA1209572A (es)
DD (1) DD242405A5 (es)
DE (1) DE3575925D1 (es)
DK (1) DK171726B1 (es)
EG (1) EG17621A (es)
ES (1) ES8701712A1 (es)
FI (1) FI82045C (es)
GR (1) GR852772B (es)
HU (1) HU197899B (es)
IE (1) IE58288B1 (es)
IL (1) IL77051A (es)
IN (1) IN164207B (es)
MY (1) MY101984A (es)
NO (1) NO854574L (es)
NZ (1) NZ214201A (es)
PH (1) PH21322A (es)
PL (1) PL149466B1 (es)
PT (1) PT81490B (es)
SU (1) SU1491339A3 (es)
YU (1) YU44019B (es)
ZA (1) ZA858773B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
AR040083A1 (es) * 2002-05-22 2005-03-16 Smithkline Beecham Corp Compuesto bis-(monoetanolamina) del acido 3'-[(2z)-[1-(3,4-dimetilfenil) -1,5-dihidro-3-metil-5-oxo-4h-pirazol-4-iliden] hidrazino] -2'-hidroxi-[1,1'-bifenil]-3-carboxilico, procedimiento para prepararlo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion farmac
ECSP077628A (es) * 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
JP2012528184A (ja) 2009-05-29 2012-11-12 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー トロンボポエチンアゴニスト化合物の投与の方法
US8648078B2 (en) * 2009-07-29 2014-02-11 Nerviano Medical Sciences S.R.L. PLK inhibitor salts
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
IN160683B (es) * 1981-06-01 1987-07-25 Pfizer
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice

Also Published As

Publication number Publication date
JPS61122284A (ja) 1986-06-10
MY101984A (en) 1992-02-29
NZ214201A (en) 1988-07-28
KR870000291B1 (ko) 1987-02-25
KR860004038A (ko) 1986-06-16
SU1491339A3 (ru) 1989-06-30
ES548878A0 (es) 1986-12-01
DK527585D0 (da) 1985-11-15
AU4995085A (en) 1986-05-22
DD242405A5 (de) 1987-01-28
HUT40116A (en) 1986-11-28
US4582831A (en) 1986-04-15
PT81490B (pt) 1988-03-03
ES8701712A1 (es) 1986-12-01
GR852772B (es) 1986-03-14
EP0182572B1 (en) 1990-02-07
IE852852L (en) 1986-05-16
JPH0425957B2 (es) 1992-05-06
EG17621A (en) 1991-08-30
YU178585A (en) 1987-12-31
ZA858773B (en) 1987-06-24
CA1209572A (en) 1986-08-12
IN164207B (es) 1989-01-28
AU556378B2 (en) 1986-10-30
CN85108245A (zh) 1986-09-03
YU44019B (en) 1990-02-28
IE58288B1 (en) 1993-08-25
DK171726B1 (da) 1997-04-14
HU197899B (en) 1989-06-28
PL256259A1 (en) 1986-10-07
PL149466B1 (en) 1990-02-28
EP0182572A1 (en) 1986-05-28
IL77051A (en) 1989-03-31
FI854512A0 (fi) 1985-11-15
PT81490A (en) 1985-12-01
DE3575925D1 (de) 1990-03-15
DK527585A (da) 1986-05-17
CN1004001B (zh) 1989-04-26
FI82045B (fi) 1990-09-28
NO854574L (no) 1986-05-20
FI82045C (fi) 1991-01-10
FI854512A (fi) 1986-05-17
IL77051A0 (en) 1986-04-29
ATE50257T1 (de) 1990-02-15

Similar Documents

Publication Publication Date Title
EG17391A (en) Process for preparing 2-(n-substituted guanidino)-4-heteroarylthiazole antiulcer agents
AU580355B2 (en) N-((4,6-dimethoxypyrimidin-2-YL)Aminocarbonyl)-3- trifluoromethylpridine-2-sulfonamide or salts thereof, herbicidal composition containing the same, and process for the production of the compound
IE870610L (en) Hydroxylamine derivatives.
CS38989A2 (en) Method of phenoxyacetamidoderivative production
IE821286L (en) Crystalline benzothiazine dioxide salts
PH25741A (en) Heterocyclic compounds, pharmaceutical composition containing said compound, method of use thereof
PH21322A (en) Anti-imflammatory polymorphic monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound; composition and method of use therefor
DE3868013D1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
PT84716A (en) Process for the preparation of insecticidal compositions containing six-membered heterocyclic derivatives of n:-substituted-n,n:-diacylhydrazines
DE3473443D1 (en) New amino derivatives of 2- (n-(2,2,5,5-tetramethyl-3-pyrrolin-or pyrrolidine-3-carbonyl))
HU182118B (en) Process for preparing 7-oxo-4-thia-1-aza-aicyclo /3,2,0/ /heptane derivatives as beta-lactamase inhibitors
EP0322765A3 (en) New thiazolidine derivatives, process for preparing same and anti-amnestic composition containing same
HUT39439A (en) Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents
PT76077B (en) Process for preparing 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives as beta-lactamase inhibitors
ZA846698B (en) Crystalline salts of l or(s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
PT78906A (en) Process for preparing 9-anthryloxyalkanes and related compounds useful as anti-inflammatory analgetic agents
PL249551A1 (en) Process for preparing crystalline amine salts of 1,1-dioxide of n-/6-methylpyridyl-2/-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carbonamide
MY102682A (en) Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds